Genmab A-S
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $5,540,000 | $5,402,000 | $4,143,000 | $4,678,000 |
Gross Profit | 5,267,000 | 5,212,000 | 3,958,000 | 4,552,000 |
EBITDA | 1,849,000 | 2,146,000 | 861,000 | 1,730,000 |
EBIT | 1,737,000 | 2,077,000 | 801,000 | 1,670,000 |
Net Income | 1,266,000 | 1,408,000 | 1,325,000 | 640,000 |
Net Change In Cash | 5,540,000 | 5,402,000 | 4,143,000 | 4,678,000 |
Free Cash Flow | 1,985,000 | 1,486,000 | 1,485,000 | 1,605,000 |
Cash | 6,342,000 | 4,331,000 | 14,670,000 | 14,867,000 |
Basic Shares | 648,847 | 648,847 | 656,590 | 657,868 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $16,474,000 | $14,595,000 | $8,482,000 | $10,111,000 |
Gross Profit | 16,248,000 | 14,595,000 | 8,482,000 | 10,111,000 |
EBITDA | 5,561,000 | 7,043,000 | 3,147,000 | 6,543,000 |
EBIT | 5,321,000 | 6,753,000 | 2,897,000 | 6,297,000 |
Net Income | 4,352,000 | 5,452,000 | 2,957,000 | 4,758,000 |
Net Change In Cash | 16,474,000 | 14,595,000 | 8,482,000 | 10,111,000 |
Free Cash Flow | 7,004,000 | 3,595,000 | 1,976,000 | 6,126,000 |
Cash | 14,867,000 | 9,893,000 | 8,957,000 | 7,260,000 |
Basic Shares | 65,914 | 660,096 | 660,457 | 658,858 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.29 |
2024-06-30 | $0.31 |
2024-03-31 | $0.29 |
2023-12-31 | $0.14 |
